PloS oneHumansCelecoxibMelanomaPropranololAdult
A randomised pilot trial of perioperative propranolol combined with celecoxib versus standard of care in stage III melanoma: The ProCel study protocol.
Katina J Selvaraj, Diona L Damian, J Guy Lyons, James S Wilmott, Peter M Ferguson, Michele McGrady, Iris Bartula, Serigne N Lo, Richard A Scolyer, Angela L Ferguson, Robyn P M Saw
Published: 202610.1371/journal.pone.0339476
Abstract
In cutaneous melanoma patients, the presence of lymph node or in transit metastasis can be associated with poor survival. Adjuvant treatment with BRAF-MEK inhibitors or immunotherapy is costly and can cause side effects, so there remains a need for s…
Preview only. Read the full abstract at the source